Automated Insulin Delivery Just Got FDA Clearance for Type 2 Diabetes. What Changes for the Pump Market
Dr. Dereck Mush, MD, MBA
UpDoc
FDA cleared clinical AI that helps manage insulin treatment plans for people with type 2 diabetes.
What they do
UpDoc received FDA 510(k) clearance (K253281) in June 2026, the first software as a medical device to use patient facing large language models. Its AI agents support insulin treatment plan management within parameters set by the physician, backed by an $18M oversubscribed seed round.
The record
- Vertical
- Primary & Virtual Care
- Sub-segment
- Diabetes care
- Product type
- Software as a medical device
- Stage
- Seed
- Headquarters
- Palo Alto, California
- Region
- North America
- Founded
- Not disclosed
- Total funding
- $18M raised
Notable investors: American Diabetes Association, Eli Lilly, Mayo Clinic.
Also in Primary & Virtual Care
Related on The Signal
Dr. Dereck Mush, MD, MBA
Everyone Is Wearing a Glucose Monitor Now. Most of Them Do Not Have Diabetes.
Dr. Dereck Mush, MD, MBA
The 33-Year Nephrology Reversal: Inside Kerendia's Type 1 Diabetes Expansion
Dr. Dereck Mush, MD, MBA
A CDMO partnership shows how gene therapy manufacturing is scaling for chronic disease
Dr. Dereck Mush, MD, MBA